Hyundai Pharmaceutical Co., Ltd.
Research Hyundai Pharmaceutical Co., Ltd. (004310.KS) on Bullrun: market cap KRW 225.38B, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker004310.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 225.38B
- Dividend yield0.5%
- Financial periodQ2 2026
- RevenueKRW 55.59B
- Net incomeKRW 1.21B
- Free cash flowKRW 1.30B
- Gross margin37.9%
Valuation Snapshot
latest market cap is KRW 225.38B; dividend yield is 0.5%.
Peer valuation comparison
Latest dividend yield is 0.45% versus a Healthcare sector median of 2.4% (81.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 225.38B | n/a | 0.4% | 30 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 30 KRW, yield 0.5%.
About Hyundai Pharmaceutical Co., Ltd.
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.
ETFs that hold Hyundai Pharmaceutical Co., Ltd.
US-listed ETFs
Hyundai Pharmaceutical Co., Ltd. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Hyundai Pharmaceutical Co., Ltd.'s market cap?
Hyundai Pharmaceutical Co., Ltd.'s market capitalization is KRW 225.38B.
Does Hyundai Pharmaceutical Co., Ltd. pay a dividend?
Hyundai Pharmaceutical Co., Ltd. has a dividend yield of 0.5%.
What does Hyundai Pharmaceutical Co., Ltd. do?
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.